Google
Trusted Resources: Community Center
Online groups, photo galleries and blogs
HealthWell Launches New Fund to Provide Financial Assistance to People with Sickle Cell Disease
The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a new fund to provide copayment and premium assistance to people with sickle cell disease (SCD). Through the fund, HealthWell will provide up to $10,000 in financial assistance for a 12-month grant period to eligible patients who have annual household incomes up to 500 percent of the federal poverty level.
+myBinderRelated Content
-
Deepika Darbari, MDDr. Darbari is a pediatric hematologist ...
-
Kids with sickle cell disease aren’t receiving key vaccines, Michigan study findsA significant proportion of children w...
-
Sickle Cell Anemia Toddlers Benefit from Maximal Hydroxyurea Doses, Study FindsIntensifying treatment with hydroxyurea ...
-
SCANJ Holiday Party South with Kenta KlausKenta Klaus (Santa's brother) invites yo...
-
SCD Patients Benefit From Early Rivipansel Treatment for VOCs, New Analyses ShowStarting treatment with rivipansel (GMI-...
-
Simon Dyson, PhDSimon Dyson is Professor of Applied Soci...
-
The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitati...Overt ischaemic stroke is one of the mos...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
